ATNF
NASDAQ180 Life Sciences Corp.
Price$7.08+6.05 (+587.86%)
2025-06-092025-08-15
Latest news
25 items- SECSEC Form PRE 14A filed by 180 Life Sciences Corp.PRE 14A - ETHZilla Corp (0001690080) (Filer)
- INSIDERChief Executive Officer Jordan Blair disposed of 200,000 shares (SEC Form 4)4 - ETHZilla Corp (0001690080) (Issuer)
- SEC180 Life Sciences Corp. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits8-K - ETHZilla Corp (0001690080) (Filer)
- SEC180 Life Sciences Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - ETHZilla Corp (0001690080) (Filer)
- SECSEC Form 424B5 filed by 180 Life Sciences Corp.424B5 - ETHZilla Corp (0001690080) (Filer)
- SECSEC Form S-3ASR filed by 180 Life Sciences Corp.S-3ASR - ETHZilla Corp (0001690080) (Filer)
- SECSEC Form S-3ASR filed by 180 Life Sciences Corp.S-3ASR - ETHZilla Corp (0001690080) (Filer)
- SECSEC Form S-3ASR filed by 180 Life Sciences Corp.S-3ASR - ETHZilla Corp (0001690080) (Filer)
- SEC180 Life Sciences Corp. filed SEC Form 8-K: Unregistered Sales of Equity Securities8-K - ETHZilla Corp (0001690080) (Filer)
- SECAmendment: 180 Life Sciences Corp. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Leadership Update, Material Modification to Rights of Security Holders, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits8-K/A - ETHZilla Corp (0001690080) (Filer)
- INSIDERFormer 10% Owner Elray Resources, Inc. sold $9,278,586 worth of shares (2,998,000 units at $3.09) and exercised 3,000,000 in-the-money shares at a strike of $1.68, increasing direct ownership by 0.15% to 1,320,000 units (SEC Form 4)4 - ETHZilla Corp (0001690080) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13D/A filed by 180 Life Sciences Corp.SCHEDULE 13D/A - ETHZilla Corp (0001690080) (Subject)
- SEC180 Life Sciences Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - ETHZilla Corp (0001690080) (Filer)
- PRETHZilla Unveils New Brand Committed to Advancing Ethereum Treasury StrategyCompany announces new ticker (formally ATNF) and will begin trading on NASDAQ under ETHZ on August 18, 2025 Company has accumulated 94,675 ETH at an average acquisition price of $3,902.20, which is now valued at approximately $419 million PALM BEACH, Fla., Aug. 18, 2025 /PRNewswire/ -- ETHZilla Corporation (NASDAQ:ETHZ), (the "Company" or "ETHZilla"), today announced the official launch of its new brand as part of the Company's transition to focus on its recently announced Ethereum treasury strategy. Previously operating as 180 Life Sciences Corp., ETHZilla will focus a significant portion of its non-legacy operations on becoming an accumulation vehicle for Ether (ETH) that is built for the
- SECAmendment: 180 Life Sciences Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K/A - ETHZilla Corp (0001690080) (Filer)
- SECSEC Form 144 filed by 180 Life Sciences Corp.144 - 180 Life Sciences Corp. (0001690080) (Subject)
- SECSEC Form 424B5 filed by 180 Life Sciences Corp.424B5 - 180 Life Sciences Corp. (0001690080) (Filer)
- SEC180 Life Sciences Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - 180 Life Sciences Corp. (0001690080) (Filer)
- SEC180 Life Sciences Corp. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits8-K - 180 Life Sciences Corp. (0001690080) (Filer)
- INSIDERSEC Form 4 filed by Executive Chairman Rudisill Mcandrew4 - 180 Life Sciences Corp. (0001690080) (Issuer)
- INSIDERSEC Form 3 filed by new insider Heter Crystal Jane3 - 180 Life Sciences Corp. (0001690080) (Issuer)
- SECSEC Form SCHEDULE 13G filed by 180 Life Sciences Corp.SCHEDULE 13G - 180 Life Sciences Corp. (0001690080) (Subject)
- SEC180 Life Sciences Corp. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits8-K - 180 Life Sciences Corp. (0001690080) (Filer)
- PR180 Life Sciences (ETHZilla) Holds 82,186 ETHCompany Initiates Institutional ETH Accumulation Strategy PALO ALTO, Calif., Aug. 12, 2025 /PRNewswire/ -- 180 Life Sciences Corp. (NASDAQ:ATNF), dba ETHZilla (the "Company", "180 Life Sciences" or "ETHZilla"), announced today that is has total holdings of 82,186 Ether ("ETH") at an average acquisition price of $3,806.71, which is now valued at approximately $349 million. In addition to the ETH, ETHZilla holds approximately $238 million in USD cash equivalents. "At ETHZilla we have put over $350 million in capital to work since the PIPE transaction we completed last week, and
- INSIDERSEC Form 4 filed by Director Shoemaker Stephen H4 - 180 Life Sciences Corp. (0001690080) (Issuer)
ATNF FAQ
7 questionsWhat does 180 Life Sciences Corp. do?
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of drug candidates in the areas of inflammatory diseases, fibrosis, and pain. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and Anti-TNF platform, which focuses on fibrosis and anti-tumor necrosis factors; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company is headquartered in Menlo Park, California.Where does ATNF stock trade?
180 Life Sciences Corp. (ATNF) is listed on NASDAQ.What sector and industry is ATNF in?
180 Life Sciences Corp. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did 180 Life Sciences Corp. go public?
180 Life Sciences Corp. (ATNF) completed its IPO in 2017.What are analysts saying about ATNF?
180 Life Sciences Corp. has had 1 recent analyst action on file. The most recent action was from Maxim Group: Buy with a $1100.00 price target on 2021-09-15. Recent price targets cluster around $1100.00.What companies are similar to ATNF?
Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare ATNF side-by-side with any of them on Quantisnow.How can I track ATNF on Quantisnow?
Quantisnow aggregates 180 Life Sciences Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ATNF to receive live email and push alerts on every new disclosure.